Journals / Alpha psychiatry (Online) / 2021 / Cilt: 22 - Sayı: 4

Management of Panic Disorder with Neurofeedbackin Patients with Muscular Dystrophy: A Case Report

Pages
219–221
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

NFB can be con sidered a safe therapeutic alternative without causing even minor side effects and withoutdrug interactions for DMD patients with panic or anxiety disorders.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Duchenne muscular dystrophy (DMD) is the most common hereditary progressive muscu lar disease.
📊
Key Findings & Data:Wereported 3 patients (2 patients with DMD and 1 patient with muscular dystrophy of anunknown etiology) with panic disorder and treated them successfully with neurofeedback(NFB).
💡
Conclusion & Impact:NFB can be con sidered a safe therapeutic alternative without causing even minor side effects and withoutdrug interactions for DMD patients with panic or anxiety disorders.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Duchenne muscular dystrophy (DMD) is the most common hereditary progressive muscu lar disease. It was recently reported that symptoms of anxiety and depression are frequentin patients with DMD, and psychosocial support is important for their quality of life. Wereported 3 patients (2 patients with DMD and 1 patient with muscular dystrophy of anunknown etiology) with panic disorder and treated them successfully with neurofeedback(NFB). The NFB protocols were slow motor rhythm at T4 for 2 patients, beta training atF3 for 1 patient, and alpha/theta training at Pz for all patients. All patients had significantlyimproved anxiety symptoms, including panic attacks, after NFB therapy. NFB can be con sidered a safe therapeutic alternative without causing even minor side effects and withoutdrug interactions for DMD patients with panic or anxiety disorders.

🔖

Cite This Article

KIM, H., KOO, B., LEE, S. W., CHEON, E. (2022). Management of Panic Disorder with Neurofeedbackin Patients with Muscular Dystrophy: A Case Report. Alpha psychiatry (Online), Cilt: 22 - Sayı: 4, 219–221. https://ajindex.com/articles/435189

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010
  2. 9(1):77-93. [CrossRef] 2. Chen YH, Lin HC. Patterns of psychiatric and physical comorbidities associated with panic disorder in a nationwide population-based study in Taiwan. Acta Psychiatr Scand. 2011
  3. 123(1):55-61. [CrossRef] 3. Hallas CN, Howard C, Theadom A, Wray J. Negative beliefs about breathlessness increases panic for patients with chronic respiratory disease. Psychol Health Med. 2012
  4. 17(4):467-477. [CrossRef] 4. Weiskopf N, Scharnowski F, Veit R, et al. Self-regulation of local brain activity using real-time functional magnetic resonance imaging (fMRI). J Physiol Paris. 2004
  5. 98(4-6):357-373. [CrossRef] 5. Cheon EJ, Koo BH, Seo WS, et al. Effects of neurofeedback on adult patients with psychiatric disorders in a naturalistic setting. Appl Psychophysiol Biofeedback. 2015
  6. 40(1):17-24. [CrossRef] 6. Bandelow B. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and agoraphobia Scale. Int Clin Psychopharmacol. 1995
  7. 10(2):73-81. [CrossRef] 7. Cheon EJ, Koo BH, Choi JH. The efficacy of neurofeedback in patients with major depressive disorder: an open labeled prospective study. Appl Psychophysiol Biofeedback. 2016
  8. 41(1):103-110. [CrossRef] 8. Moore NC. A review of EEG biofeedback treatment of anxiety disorders. Clin Electroencephalogr. 2000
  9. 31(1):1-6. [CrossRef] 9. Thomas JE, Sattlberger E. Treatment of chronic anxiety disorder with neurotherapy. J Neurother. 1997
  10. 2(2):14-19. [CrossRef] 10. Schwartz MS. Biofeedback: A Practitioner's Guide. New York: Guilford Press
  11. Bruder GE, Fong R, Tenke CE, et al. Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study. Biol Psychiatry. 1997
  12. 41(9):939-948. [CrossRef] 12. Wiedemann G, Pauli P, Dengler W, et al. Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Arch Gen Psychiatry. 1999
  13. 56(1):78-84. [CrossRef] 13. Rosenfeld JP. An EEG biofeedback protocol for affective disorders. Clin Electroencephalogr. 2000
  14. 31(1):7-12. [CrossRef] 14. Peniston EG, Kulkosky PJ. Alpha-theta brainwave training and betaendorphin levels in alcoholics. Alcohol Clin Exp Res. 1989
  15. 13(2):271-279. [CrossRef] 15. Niv S. Clinical efficacy and potential mechanisms of neurofeedback. Pers Individ D